These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4576044)

  • 1. Synergism between alloantibodies or F(ab') 2 and prednisone in the survival of murine split heart allografts.
    Svehag SE; Schilling W
    Transplantation; 1973 Mar; 15(3):344-6. PubMed ID: 4576044
    [No Abstract]   [Full Text] [Related]  

  • 2. Synergistic effect of alloantibodies or F(ab')2 and prednisone on murine split heart allograft survival.
    Schilling W; Svehag SE
    Acta Pathol Microbiol Scand C; 1976 Aug; 84(4):325-32. PubMed ID: 785946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Passive enhancement of canine renal allografts with polyspecific F(ab')2 fragments.
    Wren SF; Martins AC; Von Haefen U; Busch GJ; Katske GE; Koppenheffer TL; Shaipanich T; Wilson RE
    Surgery; 1974 Jul; 76(1):112-20. PubMed ID: 4135410
    [No Abstract]   [Full Text] [Related]  

  • 4. Prolonged survival of renal allografts in outbred rabbits treated with donor specific F(ab')2 alloantibody.
    Sutherland DE; Howard RJ; Dombrovskis S; Najarian JS
    Ann Surg; 1974 Dec; 180(6):857-63. PubMed ID: 4611361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The early effects of alloantibody and complement on rat kidney allografts.
    French ME
    Transplantation; 1972 May; 13(5):447-51. PubMed ID: 4557794
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiac transplantation in mice. II. Effect of continuous immunosuppressive therapy on the survival of H-2-incompatible allografts.
    Judd KP; Trentin JJ
    Transplantation; 1971 Mar; 11(3):303-8. PubMed ID: 4934265
    [No Abstract]   [Full Text] [Related]  

  • 7. Passive enhancement of mouse skin allografts by alloantibodies is Fc dependent.
    Capel PJ; Tamboer WP; de Waal RM; Jansen JL; Koene RA
    J Immunol; 1979 Feb; 122(2):421-5. PubMed ID: 368240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The protective effect of F(ab') 2 and succinylated IgG in the early treatment of hyperacute rejection in the primate.
    Habal MB; Carpenter CB; Kobayashi K; Bush GJ; Misra M; Birtch AG
    Transplant Proc; 1973 Mar; 5(1):601-6. PubMed ID: 4633093
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of human F(ab') 2 fragments as blocking agents in the mixed lymphocyte reaction.
    Hornung MO; Layne E; McDonald JC
    J Immunol; 1971 Oct; 107(4):979-84. PubMed ID: 4999263
    [No Abstract]   [Full Text] [Related]  

  • 10. Prolonged survival of corneal allografts incubated in alloantibody fragments.
    Gebhardt BM; Varnell ED; Kaufman HE
    Transplantation; 1999 Feb; 67(4):594-9. PubMed ID: 10071033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of organ specificity in renal allograft enhancement with F(ab') 2 fragments.
    Shaipanich T; Wren S; von Haefen U; Koppenheffer T; Busch G; Wilson RE
    Transplant Proc; 1973 Mar; 5(1):581-3. PubMed ID: 4572116
    [No Abstract]   [Full Text] [Related]  

  • 12. Active or passive enhancement and allograft survival.
    Wilson RE
    Transplant Proc; 1972 Dec; 4(4):513-5. PubMed ID: 4405144
    [No Abstract]   [Full Text] [Related]  

  • 13. Humoral antibody in canine cardiac allograft rejection.
    Goldman BS; Shumak KH; Cartier J; Silver MD; Bigelow WG; Crookston JH
    Circulation; 1971 May; 43(5 Suppl):I115-9. PubMed ID: 4931285
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunological enhancement of renal allografts.
    Stuart FP; McKearn TJ; Fitch FW
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):53-8. PubMed ID: 4140597
    [No Abstract]   [Full Text] [Related]  

  • 15. The influence of bursectomy and thymectomy on the formation of alloantibodies affecting the skin graft in ducks.
    Hasek M; Karakoz L; Hála K
    Folia Biol (Praha); 1972; 18(6):441-8. PubMed ID: 4404996
    [No Abstract]   [Full Text] [Related]  

  • 16. A quantitative comparison of whole antibody and F(ab')2 in kidney allograft enhancement.
    Winearls CG; Fabre JW; Millard PR; Morris PJ
    Transplantation; 1979 Jul; 28(1):36-9. PubMed ID: 377591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodistribution of monoclonal IgG1, F(ab')2, and Fab' in mice after intravenous injection. Comparison between anti-B cell (anti-Lyb8.2) and irrelevant (MOPC-21) antibodies.
    Holton OD; Black CD; Parker RJ; Covell DG; Barbet J; Sieber SM; Talley MJ; Weinstein JN
    J Immunol; 1987 Nov; 139(9):3041-9. PubMed ID: 3499463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of neuraminidase on serological properties of murine lymphoid cells.
    Schlesinger M; Amos BD
    Transplant Proc; 1971 Mar; 3(1):895-7. PubMed ID: 4106346
    [No Abstract]   [Full Text] [Related]  

  • 19. Preliminary studies on antithymocyte globulin.
    Orlowski T; Skopińska E; Kossowska-Paul B; Wasik M; Wojtulewicz-Kurkus J; Klopotowska E; Tupalska B; Filipowicz Z
    Pol Med J; 1971; 10(2):400-7. PubMed ID: 4997629
    [No Abstract]   [Full Text] [Related]  

  • 20. Passive enhancement of mouse tumor allografts by alloantibodies is Fc-dependent.
    de Waal RM; Cornelissen IM; Capel PJ; Koene RA
    J Immunol; 1979 Sep; 123(3):1353-5. PubMed ID: 469254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.